Small molecule-based reversible reprogramming of cellular lifespan

Jaejoon Won1, Mina Kim, Nuri Kim

  • 1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Korea.

Insights

Researchers discovered a small molecule, CGK733, that can reverse cellular senescence by selectively targeting ATM and ATR proteins. This finding offers a potential new strategy for extending human cell lifespan and combating age-related diseases.

Area of Science:

  • Cellular biology
  • Molecular medicine
  • Aging research

Background:

  • Cellular senescence is a natural process limiting normal human cell lifespan.
  • Identifying molecules to extend cell longevity remains a significant challenge in aging research.

Purpose of the Study:

  • To identify small molecules capable of reversing cellular senescence.
  • To investigate the molecular mechanisms underlying cellular aging and lifespan extension.

Main Methods:

  • High-throughput phenotypic screening with automated imaging to identify potential compounds.
  • Magnetism-based interaction capture (MAGIC) technology to identify molecular targets.
  • siRNA-mediated knockdown to validate target engagement.

Main Results:

  • CGK733 selectively inhibits ataxia telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) kinase activities.
  • CGK733 effectively reverses cellular senescence, resetting the intrinsic 'senescence clock'.
  • siRNA knockdown of ATM and ATR partially induced proliferation of senescent cells, supporting CGK733's mechanism.

Conclusions:

  • CGK733 represents a novel small molecule capable of reversibly modulating the senescence pathway.
  • Targeting ATM and ATR kinase activities offers a promising therapeutic strategy for extending cellular lifespan and potentially treating age-related conditions.

Related Concept Videos

Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...